Sage Journals: Discover world-class research

Retricted access

Research article

First published 2007-4

Patent Opposition Considerations for the Technology Transfer Professional

Mark B. Wilson, Daniel Alge

Industry and Higher Education

Retricted access

Research article

First published 2023-10

Landscape of Genome Editing Technology Patents in the European Patent Office with a Focus on CRISPR-Related Opposition Proceedings

Andreas Heiseke, Hans-Rainer Jaenichen

Biotechnology Law Report

Retricted access

Research article

First published 2008-02

Patenting Neem and Hoodia: Conflicting Decisions Issued by the Opposition Board of the European Patent Office

Kari Moyer-Henry

Biotechnology Law Report

Retricted access

Research article

First published 2006-08

BIO Opposes Changes in Patent Examination Practice;Poxvirus or Herpesvirus? It Doesn't Matter;The PTO Wants to Know . . . .;Revised Provisions for Accelerated Review;Patenting a Way to Prevent Kidney Failure?;Failure to Meet PTO Deadline Causes Appeal to Congress;Most Claims of Telomerase Patent Upheld by EPO;Short Stories: Opposition to Vaccine Patent,Allowance on Stem Cell Isolation;Press Clippings

Biotechnology Law Report

Retricted access

Research article

First published 2007-10

UK High Court Revokes Escitalopram UK Patent;Validity of Second Medical use Claims Based on Dosage Regimes in the UK;Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings

Robert Stephen

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2008-7

Patent-Related Barriers to Market Entry for Generic Medicines in the European Union: A Review of Weaknesses in the Current European Patent System and their Impact on Market Access of Generic Medicines

Lidia Mallo, Kristof Roox, Julia Pike [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 2010-04

Ablynx Succeeds in Opposition to GlaxoSmithKline Patent;Obviousness Question Requires Review;Nucleic Acid Detection Claims Are Invalid;Genetic Technologies Sues Several Companies for Infringement;State Courts Do Not Have Jurisdiction in Trade Secret Cases;Bayer,Novartis Settle Hemophilia Treatment Litigation

Biotechnology Law Report

Retricted access

Research article

First published 2015-11

Special: Theme of Clean Coal How Policy Strategies Affect Clean Coal Technology Innovation in China? A Patent-Based Approach

Ke Li, Boqiang Lin, Xiying Liu

Energy & Environment

Retricted access

Research article

First published 1990-6

Vestibular Effects of Chronic Perilymph Fistula in the Cat

Sanjay A. Bhansali, Stephen P. Cass, Jaime T. Benitez [...]

Otolaryngology–Head and Neck Surgery

Retricted access

Case report

First published 2013-9

Bayer Healthcare Pharmaceuticals,Inc. v. Watson Pharmaceuticals,Inc. : Was the decision to selectively present evidence of commercial success too “clever by half”?

Frederick H Rein, Joseph B Crystal

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Search results